Mirror Daily

Saturday, January 16, 2021
Log in
  • Home
  • National & Global News
  • Business & Economy
  • Tech & Science
  • Health
  • About Mirror Daily
    • Our Team
    • Contact Us
    • Terms of Use
    • Privacy Policy GDPR
  • Latest News
    • The Geological Features of Pluto Have Just Gotten Dark Names Inspired from the Underworld
    • The Abuse of Imodium
    • McDonald’s Salads are worse than their Burgers
    • US Family Sues Hospital Over Botched Tonsillectomy
    • Should We Go Back to The Moon?
    • Photo of Gay Military Men Kissing Goes Viral

Pages

  • About Mirror Daily
  • Contact Us
  • Fossil Reveals That Dinosaurs Suffered from Arthritis
  • Our Team
  • Privacy Policy GDPR
  • Terms of Use
  • World Breastfeeding Week: Advantages and Disadvantages

Recent Posts

  • Using Tinder Intended for Hooking Up July 6, 2020
  • An Unbiased Enjoy of Argentine Mail Buy Brides July 1, 2020
  • Positives and negatives Of Going out with Thai Women of all ages June 27, 2020
  • Living, Death and Asian Females Looking For Guy June 27, 2020
  • The Unexposed Top secret of Japanese people Brides June 25, 2020
  • East European And Slavic Birdes-to-be ᐈ Locate Top Females For Marriage Here! June 24, 2020
  • Women Dating For the First Time June 23, 2020

Swiss Drug maker Novartis Seek Approval For Two Smoker’s Cough Drugs

January 16, 2015 By Ryan Harris Leave a Comment

Swiss Drug maker Novartis is seeking U.S. regulatory approval for two drugs to treat smoker’s cough. The new drug has a market potential of $1.4 billion annually.

Positive results were obtained in the third-phase clinical tests for QVA149 and NVA237 for treating chronic obstructive pulmonary disorder, or smoker’s cough.

smokerscough

COPD kills a person every ten seconds and will become the third highest cause of mortality by the year 2030, as per a report by the WHO. Characteristic features of COPD include breathlessness, excess saliva, mucus in the airways and chronic cough. In addition to these symptoms pain in the chest, wheezing and crackling sound while breathing could also be seen in some patients

The new drugs will be pitted against GlaxoSmithKline (GSK)’s Anoro and Boehringer Ingelheim GmbH’s Spiriva. However Novartis drug could be at a disadvantage because of its twice daily dosage as compared to once daily dosage of both Anoro and Spiriva.

Filed Under: Health Tagged With: Anoro, Boehringer Ingelheim, COPD, GlaxoSmithKline, Novartis, Spiriva, WHO

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Recent Articles

Albert Einstein in group photo

Einstein’s Travel Diaries Reveal His Lesser Known Racist Side

June 14, 2018 By John Birks

Baobab tree in Tanzania

Southern Africa’s Iconic Baobab Trees Facing Massive Die-Off

June 11, 2018 By John Birks

UFO 'Self Parking' Sign

Researcher Accuses NASA of Massive Alien Cover-Up

March 5, 2018 By John Birks

Elon Musk's flying Tesla roadster

NASA Warns Elon Musk’s Flying Tesla Roadster May Contaminate Mars

February 28, 2018 By John Birks

Windows 10 home screen

Microsoft Working on Making Windows Password-Free

February 12, 2018 By John Birks

Ice Cubes

Scientists Discover Fourth State of Water: Superionic Ice

February 10, 2018 By John Birks

Head of a northern gannet

Forever Alone Nigel the Gannet Found Dead near Fake Partner

February 3, 2018 By John Birks

Globular Star Cluster

Scientists Find Surprise Black Hole in Globular Star Cluster

January 20, 2018 By John Birks

The Amazon Echo Dot

America’s Smart Speaker Market Jumps to 39 Million Users

January 15, 2018 By John Birks

Pink plasma ball

CES 2018: Intel Presents Out-of-This-World Quantum Computer

January 10, 2018 By John Birks

Teen using her iPad

Major Apple Investors Urge Company to Do More About iPhone Addiction

January 8, 2018 By John Birks

Russian spacecraft

Out-of-Control Chinese Space Station Hurling Toward Earth

January 5, 2018 By John Birks

wanning moon seen on the evening sky in between trees

Scientists Thrilled about Trump’s Initiative to Send Explorers Back to the Moon

December 31, 2017 By John Birks

Two iPhone 7 models on table

Apple Confirms Slower-iPhone Conspiracy Theory

December 22, 2017 By John Birks

Categories

  • Business & Economy
  • Capital & Retail Sector
  • Health
  • IT & Diversified Sector
  • National & Global News
  • Tech & Science

Copyright © 2021 MirrorDaily.com

About · Privacy Policy · Terms of Use · Contact

This website uses cookies to ensure you get the best experience on our website. Learn more.